CD4 and neoplasm: In response to the tumour-derived factors, both, resident and peripheral immune cells, including CD4+ regulatory T cells (Tregs), eosinophiles, monocytes and resident microglia, undergo reprogramming that results in altered secretory capacity and phagocytic functions [4,5,6,7].